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WITH DIFFERENT MUTANT SELENOCYSTEINE tRNAs LACKING
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Novel mouse models were developed in which
the hepatic selenoprotein population was
targeted for removal by disrupting the
selenocysteine (Sec) tRNA[Ser]Sec gene (trsp) and
then selenoprotein expression was restored by
introducing wild type or mutant trsp
transgenes. The selenoprotein population was
partially replaced in liver with mutant
transgenes encoding mutations at either
position 34 (T34->A34) or 37 (A37->G37) in
tRNA[Ser]Sec. The A34 transgene product lacked
the highly modified 5-methoxycarbonylmethyl2’ O-methyluridine and its mutant base A was
converted to I34. The G37 transgene product
lacked
the
highly
modified
N6isopentenyladenosine. Both mutant tRNAs
lacked the 2’-methylribose at position 34
(Um34), and both supported expression of
housekeeping selenoproteins (e.g., thioredoxin
reductase 1) in liver, but not stress-related
proteins (e.g., glutathione peroxidase 1). Thus,
Um34 is responsible for synthesis of a select
group of selenoproteins rather than the entire
selenoprotein population. The ICA anticodon in
the A34 mutant tRNA decoded Cys codons,

UGU and UGC, as well as the Sec codon, UGA.
However, metabolic labeling of A34 transgenic
mice with 75Se revealed that selenoproteins
incorporated the label from the A34 mutant
tRNA, whereas other proteins did not. These
results suggest that the A34 mutant tRNA did
not randomly insert Sec in place of Cys, but
specifically targeted selected selenoproteins.
High copy numbers of A34 transgene, but not
G37 transgene, were not tolerated in the
absence of wild type trsp further suggesting
insertion of Sec in place of Cys in
selenoproteins.
There are 24 known selenoproteins in rodents
and 25 in humans (1). The targeted removal of
specific selenoproteins has shown that some are
essential in development whereas others appear to
be non-essential. For example, the loss of
selenoproteins glutathione peroxidase 4 (GPx4; 2),
or thioredoxin reductase 1 (TR1 or Txnrd1; 3) or 2
(TR3 or Txnrd2; 4) is embryonic lethal, while the
loss of glutathione peroxidase 1 (GPx1; 5) or 2
(GPx2; 6) appears to be of little or no
consequence. Other studies, however, suggest that
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2
secondary and tertiary structure (18). Um34
addition is dependent on the prior synthesis of the
four modified bases found in tRNA[Ser]Sec and on
an intact tertiary structure (19). Synthesis of all
other modified nucleosides of Sec tRNA[Ser]Sec,
including mcm5U, is less stringently associated
with primary and tertiary structure. In addition,
synthesis of Um34 is dependent on the selenium
status of the organism, with increased dietary
selenium increasing Um34 levels (17).
Removal of trsp is embryonic lethal (20,21).
Therefore, to alter the Sec tRNA[Ser]Sec population,
techniques of influencing Sec tRNA[Ser]Sec levels
other than the sole removal of trsp must be
employed. We previously generated transgenic
mice with extra copies of wild type or mutant Sec
tRNA[Ser]Sec transgenes (22), and mice with a
conditional knockout of trsp (21), and then
rescued selenoprotein expression in trsp null mice
with wild type or mutant Sec tRNA[Ser]Sec
transgenes (23,24). Consistent with reports that the
Sec tRNA[Ser]Sec population is not limiting in
selenoprotein biosynthesis (20,22,25), we found
little or no effect of extra copies of wildtype
transgenes on selenoprotein expression in the
tissues and cells examined (22). In contrast,
multiple copies of a mutant trsp transgene can lead
to specific altercations in the selenoprotein
population (22). For example, transgenes with a
mutation at position 37 (A37->G37) produce a
tRNA gene product that not only lacks
isopentenyladenosine (i6A) at this site, but also
lacks Um34 (19). Selenoprotein synthesis was
affected in mice carrying the G37 Sec tRNA[Ser]Sec
transgene in a protein- and tissue-specific manner
(22). Rescue of selenoprotein expression in trsp
null mice with the G37 Sec tRNA[Ser]Sec transgene
results in the recovery of housekeeping
selenoproteins, while numerous stress-related
selenoproteins that are non-essential to survival
are either not rescued, or are poorly rescued
(23,24).
Although the wild type and mutant trsp
transgenic models and transgenic-trsp rescue
models have provided considerable insight into
selenoprotein expression and the hierarchy of
selenoprotein expression (21-24), they have
limitations. For example, when expressing mutant
trsp transgenes in mice carrying the endogenous
allele of trsp, expression from the wildtype trsp
can confound the studies. Studies with rescue
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those selenoproteins whose loss results in little or
no phenotypic change may function in protective
mechanisms against certain environmental stresses
(see 6 and references therein). There are
selenoproteins whose removal or mutation results
in dramatic effects on health. For example,
knockout of selenoprotein P (SelP) causes
neurological problems (7,8) and knockout of type
2 iodothyronine deiodinase results in a variety of
defects including an impaired
adaptive
thermogenesis and hypothermia in cold-exposed
mice (see 9 and references therein), retarded
cochlear development and hearing loss (10) and a
pituitary resistance to T4 (11). Mutations affecting
selenoprotein N (SelN) result in several muscle
disorders (12,13).
LoxP-Cre technology, which allows the
removal of embryonic lethal genes in specific
tissues and organs (3,4,14), has been used to
examine the roles of essential selenoprotein genes
in development and health. Such studies have
elucidated key roles of TR1 in embryogenesis of
numerous tissues and organs, except heart (3), and
of TR3 in hematopoiesis and in heart development
and function (4). The targeted removal of the
nuclear form of GPx4 (designated snGPx4) results
in viable and completely fertile animals, although
the overall structural stability of sperm chromatin
is diminished (14). Loss of SelP in liver, achieved
by targeted knockout of the selenocysteine (Sec)
tRNA[Ser]Sec gene (designated trsp), implicated
SelP in transport functions in plasma, and
substantiated its essential role in brain (15).
Selenoprotein synthesis is dependent on the
presence of Sec tRNA[Ser]Sec. Given this
dependence, selenoprotein expression can be
modulated by perturbing Sec tRNA[Ser]Sec
expression, providing a means of elucidating the
role of selenoproteins and selenium in
development and health (16). The Sec tRNA[Ser]Sec
population in higher vertebrates consists of two
isoforms that differ by a single 2’O-methyl group.
One
isoform
contains
5methoxycarbonylmethyluridine
(mcm5U)
at
position 34 and the other is methylated on the
ribosyl moiety at that position generating 5methoxycarbonylmethyl-2’O-methyluridine
(mcm5Um; 17). The presence of this 2’-methyl
ribose modification (designated Um34) confers
several unique properties on mcm5Um. For
example, Um34 affects Sec tRNA[Ser]SecmcmUm

3

EXPERIMENTAL PROCEDURES
Materials - 75Se-selenium (specific activity 1000
Ci/mmol) was obtained from the Research Reactor
Facility, University of Missouri, Columbia, MO,
3
H-serine (specific activity 29 Ci/mmol) from
Amersham and 32P-α-dCTP (specific activity
~6000 Ci/mmol) from Perkin Elmer. Hybond
Nylon N+ membranes were purchased from
Amersham, NuPage 10% polyacrylamide gels,
polyvinylidene difluoride (PVDF) membranes,
Superscript II reverse transcriptase and SeeBlue
Plus2 protein markers from Invitrogen,
SuperSignal West Dura Extended Duration
Substrate from Pierce, Universal Reference RNA
from Stratagene, ADP Sepharose 4B resin from
GE Healthcare and anti-rabbit-HRP and antichicken-HRP conjugated secondary antibodies

from Sigma. Reagents for the TR1 assay (22) were
purchased from Sigma Aldrich. Antibodies against
GPx1 were obtained from Abcam and antibodies
against GPx4, TR1, TR3, SelR, and SelT were
from our laboratories (1,24,27). All other reagents
were obtained commercially and were products of
the highest grade available.
Animals and genotyping of mice – Homozygous
floxed trsp C57BL/6 mice (trspfl) that were also
homozygous for albumin Cre (AlbCre) were
designated Δtrsp after trspfl was removed by the
Cre recombinase (23,24,27). Δtrsp C57BL/6FVB/N transgenic mice were homozygous for one
of three types of trsp transgene (trspt) alleles as
follows: 1) wild type transgene encoding 10 copies
of wild type trspt/allele (22); 2) G37 low or high
copy transgene encoding either 1 (low) or 8 (high)
copies of the A37->G37 mutant trspt/allele; or 3)
A34 transgene encoding one copy of the T34->A34
mutant trspt/allele. The product of the G37
transgene lacks the highly modified base, i6A, at
position 37 and also Um34. The single copy G37
transgenic mouse was generated specifically for
this study (22) to compare to the effects of the
single copy A34 transgene. The product of the A34
transgene lacked the highly modified base,
mcm5U, and also lacked Um34. T34->A34
transgenic mice were generated exactly as
described (22) except that the transgene construct
contained an A at position 34 instead of a T and
the base at position 37 was the wild type A base;
and three founders that were heterozygous for 1, 4
and 6 transgene copies were obtained. A34
transgenic mice were in strain FVB/N and
founders were bred to obtain the corresponding
homozygous mice (designated A34-2, A34-8 and
A34-12, respectively).
Genotype designations and definitions are
given in the legend of Table 1. All mice used in
this study were males. Matings to obtain mouse
lines carrying wild type, A34 and G37 transgenes
and Δtrsp in their liver are summarized in Table 1.
Primers used for detecting trsp, trspfl, Δtrsp,
trspt, G37 or A34 by PCR are designated CKNO2
(forward primer) and RES1 and VP1 (reverse
primers) (see Fig. 1 and ref 27). Primers used for
detecting AlbCre are designated LIV1 (forward
primer) and LIV2 (reverse primer) (see Fig. 1 and
28 and references therein). The care of animals
was in accordance with the National Institutes of
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models like that described above, with a germline
conditional trsp allele, focus on the selenoprotein
population in the whole animal. The targeted
removal of floxed trsp in defined cell types using
transgenic mice with tissue-specific expression of
Cre recombinase permitted some study of the
effects of selenoprotein loss in specific tissues and
organs in the absence of endogenous trsp.
However, the resulting animals have a variety of
defects including embryonic mortality or early
adult death (26) restricting the use of these models
for studying the role of selenium and
selenoproteins in health.
In the present study, we generated a mouse
model that targets the removal of trsp in liver for
use in elucidating the role of selenium and
selenoproteins and the contributions of
housekeeping and stress-related selenoproteins in
health. trsp loxP-albumin Cre mice (27) were
crossed with i6A-Um34 deficient Sec tRNA[Ser]Sec
transgenic mice (designated herein as G37
transgenic mice; (22)) or with another mutant trsp
(T34->A34) transgenic mouse described herein
that lacks mcm5U and consequently the Um34
modification (designated herein as A34 transgenic
mice). The resulting mouse lines lacks trsp in liver
and are dependent on the A34 mutant transgene or
the G37 mutant transgene for selenoprotein
expression. These new mouse models provide us
with novel experimental systems for investigating
the role of numerous stress-related selenoproteins
in health in a specifically targeted organ.

4
and references therein). TR1 activity was
determined in cytosol-enriched protein extracts
using the insulin reduction method (8).
The amount of selenium in extracts of liver,
kidney, testes, brain and plasma was determined
by Oscar E. Olsen Biochemistry Laboratories at
South Dakota State University as described
(23,27).
Isolation, aminoacylation, fractionation, and
sequencing of tRNA and coding studies - Total
tRNA was isolated from liver of each mouse line.
The tRNA was aminoacylated with [3H]serine (29)
and the resulting aminoacylated tRNA fractionated
on a RPC-5 column (30) as described (22,23,27).
Sec tRNAs that were synthesized intracellularly
from the A34 mutant transgene encoding a base
change were sequenced using an RT-PCR
technique (31) in which individual fractions from
the RPC-5 columns were used as designated in
Fig. 6. Codon recognition studies were carried out
on 3H-seryl-tRNA[Ser]Sec fractions from the RPC-5
column using the ribosomal binding technique of
Nirenberg and Leder (32) as described (29).
Trinucleoside diphosphates AGA, GGA, CGA,
UGA, UGU and UGC were the gift of Marshall
Nirenberg or were prepared as described (29).
RESULTS AND DISCUSSION
Characterization of transgenic mice carrying the
A34 mutant trsp transgene – Founder mice
containing 1, 4 and 6 copies (heterozygous
animals) of the A34 mutant transgene were
generated as described in the Experimental
Procedures. Each mouse line was bred to yield
homozygous trsp transgenic animals and the
resulting lines were characterized in parallel with
transgenic mice carrying low and high copy
numbers of wild type or G37 trspt transgenes (22).
To determine the effects of A34 transgenes on
selenoprotein biosynthesis, wild type and A34
transgenic mice carrying 4 or 12 copies of mutant
transgenes were labeled with 75Se and the resulting
labeled selenoprotein population analyzed (Fig. 1).
The highest A34 transgene copy number inhibited
GPx1 expression, while TR1 expression showed
little change in liver and kidney of both A34
transgenic mice. Thus, the low copy A34 transgene
number appeared to have only a minor effect on
overall synthesis of selenoproteins. Similar
observations were reported previously for the G37
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Health institutional guidelines under the expert
direction of Dr. Kyle Stump (National Cancer
Institute, National Institutes of Health, Bethesda,
MD).
75
Se-Labeling of selenoproteins - Mice were
injected intraperitoneally with 50 μCi of 75Se/g
and sacrificed 48 hrs after injection as described
(see 23,27 and references therein). Tissues and
organs were excised, immediately frozen in liquid
nitrogen and stored at –80oC. Tissues were
homogenized and 40 µg of protein were
electrophoresed on NuPage 10% polyacrylamide
gels. Gels were stained with Coomassie blue, dried
and exposed to a PhosphorImager as described
(23,27 and references therein). To further assess
75
Se-labeling of TR1, the labeled protein was
purified from crude extracts of tissue using ADP
Sepharose 4B prior to gel electrophoresis as
described (22). TR3 is also enriched by the ADPSepharose procedure, but the amounts of TR3
relative to TR1 are only about 10% and likely not
to influence overall levels of the TR population
(e.g., in Fig. 3B).
Northern and Western blot analyses - Total RNA
isolated from liver and kidney was analyzed by
Northern blot hybridization using 32P-labeled
probes. Membranes were analyzed with a
PhosphorImager as described (23,27). Deiodinase1 (D1), GPx1, GPx4, SelK, SelP, SelR, SelW,
Sep15, selenophosphate synthetase-2 (SPS2), and
TR1 probes were used (23). The remaining probes
were generated by RT-PCR using Superscript II
reverse transcriptase and Universal Reference
RNA or mouse liver RNA (23,27).
Protein extracts were prepared from liver and
kidney and electrophoresed on NuPage 10%
polyacrylamide gels. Proteins were transferred to
PVDF membranes as previously described with
the exception that 40 μg of each protein extract
were loaded onto gels (21-23,27) and
immunoblotted with antibodies against GPx1
(1:1000 dilution), GPx4 (1:2000), SelR (1:1000)
and SelT (1:400). Anti-rabbit-HRP conjugated
secondary antibody (1:30000) was used in all
Western blots. Membranes were washed with
0.1% TBS-T, incubated in SuperSignal West Dura
Extended Duration Substrate and exposed to X-ray
film.
GPx and TR1 activities and selenium assays Total GPx activity was measured using a standard
assay with hydrogen peroxide as substrate (23,27

5
Δtrsp extract. Identification of this band as
glutathione S-transferase and its possible
significance were reported elsewhere (27).
Another protein band which migrated near 20 kDa
was observed to vary in amounts in liver of mutant
Sec tRNA[Ser]Sec mouse lines (see arrow with a
question mark in lower liver panel in Fig. 3). This
band did not vary reproducibly in livers from
mutant trsp mice and therefore we have not
identified it.
Variations were observed in the selenoprotein
labeling patterns within organs and tissues of mice
with the six different genotypes, particularly in
liver between the two control mice containing wild
type trsp and trspt and the four mouse lines
containing the defective tRNAs[Ser]Sec (Fig. 3).
Some 75Se-labeled bands have been previously
identified, including TR1, GPx1, GPx4 and Sep15,
which are indicated in the liver panel (23,27,33).
SelW, indicated with a question mark, has been
tentatively identified (see 27 and references
therein). The band that migrates just below TR1 is
likely selenophosphate synthetase 2 (SPS2),
although SelP also migrates at this position (1).
GPx3 and SelP, which are indicated in the plasma
panel, have been characterized in plasma (27 and
references therein).
The selenoprotein labeling patterns from trsp
and trspt control mice (lanes 1 and 2, respectively,
in each panel of Fig. 3) were similar with some
minor differences. For example, GPx1 and GPx4
appeared to be more enriched in kidney (control
tissue), and liver of trspt mice than in the
corresponding tissues in trsp mice. Comparison of
mice encoding wild type trsp to those lacking trsp
in liver (Δtrsp) showed that, as expected, most of
the selenoprotein population is absent in Δtrsp
liver. The minor selenoprotein bands observed in
Δtrsp mice are likely proteins from liver cell types
other than hepatocytes (27) which is the only cell
type in which trsp deletion is targeted (28).
The presence of the A34 or G37 mutant
transgenes in Δtrsp mice resulted in TR1 and
GPx4, and possibly SelP and/or selenophosphate
synthetase 2 (SPS2), being restored in liver. The
selenoprotein-labeled population in kidney
appeared to be similar in the four tRNA[Ser]Sec
defective mouse lines with the possible exceptions
of a reduced level of GPx1 in the high copy G37
transgene line (Fig. 6) and the elevated levels of
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transgene carrying similar trspt copy numbers
(22). These data suggested that the mutations at
position 34 and 37 in Sec tRNA[Ser]Sec, which both
result in loss of Um34, had similar effects on the
expression of selected selenoproteins.
Replacement of housekeeping selenoproteins in
liver – Mouse lines carrying the targeted removal
of trsp in liver (Δtrsp) and carrying either A34,
low or high copy G37 transgenes, or the wild type
(trspt) transgenes were generated (See Table 1).
Importantly, trsp is not expressed in liver, while it,
along with each transgene, is expressed in all other
organs and tissues. Thus, the effects of the
transgene products on selenoprotein expression
and function occur independently of the wild type
gene only in the trsp targeted organ. Since the trsp
and trspt mouse lines express wild type Sec
tRNA[Ser]Sec and over-expression of trsp has little
or no effect on selenoprotein synthesis
(17,20,21,22,37), they both were considered as
controls. Genotypes were determined in liver and
kidney, as the affected and control organs,
respectively, and the expected genotypes were
found as shown in Fig. 2.
Attempts to restore the housekeeping
selenoprotein population in liver of Δtrsp mice by
mating with A34 transgenic mice carrying a higher
copy number of A34 transgenes than the 2 copies
used in replacing selenoprotein expression in these
mice were unsuccessful. In addition, we were not
able to rescue trsp null mice with any A34
transgenic mice regardless of the transgene copy
number. Furthermore, the number of matings to
obtain restored selenoprotein expression in Δtrsp
liver with the A34 transgene exceeded, by more
than three-fold, those required to obtain the A37
and trspt selenoprotein liver replacement mice.
These findings and their implications are further
discussed below in the section Consequences of
A34 Sec tRNA[Ser]Sec in selenoprotein synthesis.
75
Se-Labeling - The expression of selenoproteins
in liver, kidney, testis, brain, heart and plasma of
the six mouse lines was examined by labeling
animals with 75Se and analyzing labeled proteins
in tissue extracts following gel electrophoresis.
Coomassie blue-stained gels of total proteins (Fig.
3A, lower panels) from the different tissues served
as loading controls and similar patterns and
amounts of total proteins from the same tissues
were observed with the possible exception of an
enriched band indicated with an arrow in the liver

6
SelR mRNA was reduced in liver of high copy
G37 transgenic mice, but remained at similar
levels in liver and kidney of the other mice with
only slightly lower amounts in liver of the low
copy G37 transgenic and Δtrsp mice. The level of
SelK mRNA was similar in the mouse lines
examined with the exception of a slightly reduced
level in liver of Δtrsp mice. The mRNA levels of
the other selenoproteins examined appeared to be
present in similar amounts in both tissues of the
six mouse lines or to vary only slightly in the four
tRNA[Ser]Sec defective mice as compared to those of
the controls.
Selenium status - The selenium levels were
determined in liver, kidney, testes, brain and
plasma (Table 2). The amounts of selenium were
similar in each tissue of the trsp and trspt control
mice with the exception of liver and kidney that
appeared to have a somewhat higher selenium
level in mice carrying the trspt transgene. The four
defective tRNA[Ser]Sec mice had lower, but similar
levels in liver, kidney and plasma compared to the
two control mice, while A34 and the low copy G37
transgenic mice had similar levels as the two
controls in testes and brain. The high copy G37
transgenic and Δtrsp mice had similar, but slightly
lower selenium levels than the two other
transgenic defective mice in testes.
Western blot analysis – The expression levels of
several selenoproteins were further examined by
Western blot analyses. Because GPx1, SelR and
SelT were not rescued in an earlier study involving
the G37 transgene (23,24), as assessed by Western
blot analysis, we focused on these selenoproteins
to determine whether they might be restored in
liver by the A34 transgene. GPx4 expression was
also examined since its 75Se-labeling patterns
varied in liver and kidney within the different
mouse lines (Fig. 3).
GPx1 was not detected in liver of Δtrsp mice,
or in liver of mice carrying either the A34 or G37
transgenes (Fig. 5). GPx1 was present in lower
levels in kidney of Δtrsp, A34 and low copy G37
transgenic mice than in the other mice, and was
not detected in kidney from high copy G37
transgenic mice. The relative amounts of GPx1
were similar in kidney of Δtrsp and A34 mice, but
less than observed in the low copy G37 transgenic
mouse. Possible reasons for these differing levels
of GPx1 expression are further considered below.
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GPx1 and 4 in Δtrsp. The higher number of
transgenes in high copy G37 than A34 would also
seem to account for the reduced amounts of GPx1
observed in the other tissues. The G37 low copy
number and A34 transgenes resulted in similar
effects in labeling in the tissues examined except
plasma. SelP, which is synthesized largely in the
liver and transported to other tissues (see 15 and
references therein), is reduced in plasma of A34
and G37 mice and possibly in testes of these
mouse lines compared to control mice. SelP is also
reduced in plasma in Δtrsp mice compared to the
two control mice, trsp and trspt. These
observations are further considered below in the
section on Consequences of A34 Sec tRNA[Ser]Sec in
selenoprotein synthesis.
GPx4 also appeared to be slightly enriched in
testes of several mouse lines compared to trsp
mice. GPx levels were further examined by
measuring GPx activity in each tissue of the six
mouse lines (see GPx assays below and in Table
1).
To examine the 75Se-labeling of TR1 in liver
and kidney in more detail, TR1 was enriched from
these tissues by passing tissue extracts over an
ADP-Sepharose 4B affinity column (22). As
shown in Fig. 4B, similar amounts of TR1 were
present in both tissues of each mouse line with the
exception of liver from Δtrsp mice which
expressed TR1 poorly. In addition, TR1 appeared
to be slightly enriched in kidney of Δtrsp mice and
possibly in both tissues of trspt mice.
Northern blot analysis - Analysis of mRNA
levels is an alternative means of examining the
status of selenoprotein expression. The presence of
UGA in the coding region targets some
selenoprotein mRNAs for nonsense mediated
decay (NMD; 34,35). As shown previously
(34,35), NMD of some selenoprotein mRNAs is
dependent on selenium status (see also reviews in
17,36). GPx1 mRNA was present in low, but
detectable levels, in liver of the four tRNA[Ser]Sec
defective mice compared to those of the two
control mouse lines (Fig. 4). The levels of SelW
mRNA were reduced substantially in liver of the
four tRNA[Ser]Sec defective mice and in reduced
levels in kidney of A34 and high copy G37
transgenic mice. SelT mRNA levels were reduced
in liver of the four tRNA[Ser]Sec defective mice, but
present in similar levels as control mice in kidney.

7
GPx activity was increased or decreased. In liver,
where most of the GPx activity is due to GPx1, the
activities were similar in the two control mice, trsp
and trspt, but extremely low in Δtrsp mice and
Δtrsp mice carrying either the A34 or G37
transgene. In the other tissues examined, GPx
levels were also similar in the two control mice.
However, non-liver tissues of the four tRNA[Ser]Sec
defective mouse lines had variable amounts of
GPx activity. For example, in kidney, GPx
activities were reduced in the Δtrsp mice or mice
carrying A34 and low copy G37 transgenes, but
were even lower in mice carrying the high copy
G37 transgene. Testes and brain had normal GPx
activities in the Δtrsp mice, whereas mice
encoding the A34 and low copy G37 transgenes
had reduced activities, and those encoding the high
copy G37 transgene had even lower levels. Plasma
had low and similar activity levels in the four
defective tRNA[Ser]Sec mouse lines, although the
levels in low copy G37 mice appeared to be
slightly higher. Thus, the mutations in trsp did not
support full GPx1 activities. In particular, the high
copy G37 transgene apparently exerted dominant
negative effects in kidney and brain even in the
presence of wildtype trsp alleles, since GPx
activities in high copy G37 mutants were below
the levels in Δtrsp mutants. These observations
appear to exclude simple effects due to impaired
selenium transport to these tissues.
Interestingly, GPx activities in kidney of Δtrsp
mice were lower than in control mice even though
kidney was not the targeted tissue (Table 3). We
have proposed that this is a result, at least in part,
of reduced selenoprotein P (SelP) expression and
thus impaired selenium transport of SelP from
Δtrsp liver to kidney (15). The selenium levels
observed in kidney in the present study were lower
in Δtrsp mice than control mice (Table 2). This
result seems to conflict with a previous study with
the same mouse lines (27), but gender differences
likely explain this apparent conflict. In the present
report, male mice were analyzed, while in the
earlier study, female mice were studied (27). We
have recently described lower selenium levels and
GPx activities in mutant kidneys from male Δtrsp
mice (15). Since gender-differences were observed
in these experiments and female Δtrsp mice were
less affected than male mutants (U.Schweizer,
unpublished data), the gender-specific differences
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GPx4 was present in liver of low copy G37
transgenic mice and was virtually absent in liver
from the other three tRNA[Ser]Sec defective mice.
This selenoenzyme appeared to be reduced, but
present in kidney of Δtrsp, A34 and low copy G37
transgenic mice and virtually absent in high copy
G37 transgenic mice. SelR was poorly expressed
in liver of both G37 transgenic mouse lines
relative to control mice, but slightly better
expressed in A34 mice. SelR was also not
expressed in kidney of the high copy G37 mice
and weakly expressed in the other tRNA[Ser]Sec
defective mice (Fig. 5), although SelR mRNA was
expressed in this tissue (Fig. 4). Interestingly, SelT
was not expressed in kidney of high copy G37
mice and partially or poorly expressed in kidney or
liver of the tRNA[Ser]Sec defective mice (Fig. 5)
even though its mRNA appeared to be synthesized
in sufficient levels within these tissues for
adequate translation (Fig. 4).
The combination of reasonable mRNA levels
with low protein levels strongly suggests that the
defect in stress-related selenoprotein synthesis in
the mutant trspt mice is in translation rather than
via effects on mRNA stability. More specifically,
these findings raise the possibility that NMD of
selenoprotein mRNAs (34,35) results from a block
to translation due to the absence of the Um34
isoform. The corresponding mRNA with the
encoded NMD criteria are then degraded. The site
of regulation of mRNA decay may therefore be the
Um34 methylation step that is known to be
sensitive to selenium status (37). In fact, the Um34
isoform is dramatically reduced during selenium
deficiency leading us to speculate that phenotypes
displayed by the A34 and G37 transgene lines
(Northern data shown in Fig. 4 and Western data
shown in Fig.5) likely mimic those provoked by
selenium-deficient conditions, thus pinpointing
this phenomenon as a failure of mRNA translation
by the Um34 isoform.
Glutathione peroxidase and TR1 activities –
Since the labeling of GPx1 and GPx4 with 75Se
appeared to be enhanced in kidney of trspt, Δtrsp,
A34 and low copy G37 mice (Fig. 3), but their
levels were diminished in this tissue as assessed by
Western blotting (Fig. 5), we examined the
cytosolic GPx activities in kidney and several
other tissues from the six mouse lines (Table 3,
Expt I). The assay did not distinguish between the
different peroxidases but reveals whether total
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mouse was excluded because it had been
examined previously (27). The endogenous wild
type Sec tRNA[Ser]Sec was absent in liver of Δtrsp
mice (data not shown) which allowed us to
examine the A34 mutant tRNA population without
any influence of host wild type tRNA. Total tRNA
was isolated from liver of the five mouse lines,
aminoacylated with 3H-serine and the resulting 3Hseryl-tRNA isoforms chromatographed over a
RPC-5 column. The elution profile of the
tRNA[Ser]Sec population from the A34 replacement
mouse is shown in Figure 6. The mutant tRNA
eluted from the column as two major peaks. A
small aliquot of two fractions from each peak was
taken for sequencing, while the remainder of each
peak was pooled for coding studies. The codon
recognition properties of Peak I demonstrated that
it decoded UGU, UGC and UGA (Fig. 6)
suggesting that the anticodon was ICA. Peak II
decoded UGU suggesting that its anticodon was
ACA. Sequences of two separate fractions of Peak
I showed that the base in the wobble position was
G, which corresponds to I in the actual sequence
(31). The anticodon was therefore ICA. Sequences
of the two fractions of Peak II demonstrated that
the base in the wobble position was A and the
anticodon was ACA. The distributions of Peaks I
and II were 66.6 and 33.4%, respectively. The
elution profiles of 3H-seryl-tRNA[Ser]Sec from the
other mouse lines, with the exception of that from
the Δtrsp mouse line, are shown in the inset in
Figure 6.
Um34
is
important
for
stress-related
selenoprotein expression – The A34 and G37
mutations result in the loss of highly modified, but
very different bases, mcm5U in A34 and i6A in
G37. The common feature of these mutant tRNAs
is that they lack Um34. The two tRNAs are clearly
capable of decoding Sec UGA codons as both
support selenoprotein synthesis in mouse liver
lacking wild type Sec tRNA[Ser]Sec (see Figs. 3 and
5), but neither is able to restore stress-related
selenoprotein synthesis in liver following trsp
knockout (Fig. 5). Although minor differences
were observed in mRNA stability of certain
selenoprotein mRNAs and in levels of certain
selenoproteins, the overall effects of both mutant
tRNAs were similar providing strong evidence that
the Um34 Sec tRNA[Ser]Sec isoform is responsible
for stress-related selenoprotein synthesis. The
minor differences in the effects of the two tRNAs
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in expression of prototype selenoenzymes in major
organs of the mouse were systematically explored
(38,39). GPx and deiodinase type I activities were
higher in female kidney compared to male kidney,
while hepatic deiodinase type I activity was higher
in male compared to female mice. Since GPx
activity is a good indicator of tissue selenium
content, it would seem that the reduced selenium
level detected in kidney of Δtrsp mice compared to
that of control mice (Table 2) may account in part
for the lower GPx activities found in Δtrsp mice,
while an additional dominant negative effect of
high copy G37 further reduced kidney GPx
activity. It should also be noted that the
observation of gender differences with respect to
selenium metabolism in rodents is not a recent
one. For example, Burk and collaborators found
that male rats were more affected by selenium
deficiency than female rats and the nutritional
requirement for selenium is higher in males than
females (40).
The Western blot analysis of GPx1 and GPx4 in
liver and kidney (Fig. 5) were in closer agreement
with the direct GPx enzyme assays (Table 1, Expt
1) than with the 75Se-labeling data (Fig. 3). This
discrepancy almost certainly reflects variations in
both selenoprotein pool sizes and turnover rates
that would influence patterns of 75Se-labeling. In
addition, the A34 tRNA[Ser]Sec isoform may also
insert Sec in place of Cys in response to certain
Cys codons, UGU and UGC, that would also
affect labeling patterns as well as the activity and
Western blot analysis (see section below on
Consequences of A34 Sec tRNA[Ser]Sec on
selenoprotein synthesis).
TR1 assays were also carried out in liver and
kidney of the six mouse lines (Table 3, Expt II).
TR1 activities were similar in kidney of each
mouse line except in high copy G37 which was
about half that of controls. In liver, Δtrsp had low,
detectable activity which was likely due, for the
most part, to liver cell types other than hepatocytes
(27). TR1 activity was recovered with the three
mutant transgenes, but low copy G37 was slightly
less than controls, high copy G37 about half that
of controls and A34 slightly less than that of low
copy G37.
Fractionation, sequencing and codon recognition
of T34->A34 Sec tRNA[Ser]Sec - The Sec tRNA[Ser]Sec
population was examined in liver from five of the
six mouse lines. The low copy G37 transgenic
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Sec decoding machinery (i.e., SECIS elements
(41) and EFsec (42,43)) which are required for
incorporation of Sec into protein. These mutant
tRNAs probably insert Sec at some Cys codons in
selenoprotein mRNAs with insertion governed by
the same criteria that control Sec insertion at UGA
(location of the Sec UGA codon relative to the
SECIS element, for example, 44,45). These tRNAs
would likely compete with tRNACys for decoding
specific Cys codons.
Replacement of Cys with Sec in selenoproteins
would most likely result in lower enzymatic
activity as is found in the GPxs in the mutant
tRNA lines (Table 3). That the level of SelP was
severely reduced in the presence of the A34
transgene (see plasma panel in Fig. 3) supports the
idea of competition, but also may indicate that a
protein with multiple amino acid replacements is
more rapidly degraded and/or poorly transported.
Clearly, SelP has multiple Sec and Cys residues
and the repeated use of a Sec tRNA[Ser]SecICA and/or
ACA would likely result in reduction in overall SelP
expression.
Competition of Cys and Sec codons for
tRNA[Ser]Sec may explain the inability to rescue trsp
null mice with any A34 transgenic mouse
regardless of the transgene copy number even
though the same breeding scheme successfully
rescued trsp null mice using wild type or G37
transgenic mice (23,24). We were able to restore
selenoprotein expression in liver of mice targeted
for removal of Δtrsp with A34 transgenic mice
carrying two copies of the mutant transgene, but
not with higher copy numbers employing the same
breeding scheme as that which replaced
selenoprotein expression with trspt and G37
transgenes. Sec tRNA[Ser]Sec isoforms with
anticodons ACA and ICA may compete more
effectively with Cys tRNA in decoding
selenoprotein mRNAs and insert Sec in place of
Cys disrupting function and resulting in lethality.
Although high copy numbers were tolerated by
A34 transgenic mice, these animals also had wild
type trsp.
Significance of developing novel mouse models –
Selenium is reported to have many health benefits
including roles in preventing cancer, heart disease
and other cardiovascular diseases, in delaying the
aging process and the onset of AIDS in HIV
positive patients, male fertility, immune function,
mammalian development and viral inhibition (46).
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on selenoprotein synthesis are likely due to the
loss of the large, highly modified base in each
mutant tRNA. Furthermore, the fact that selenium
deficiency in rodents mimics the effects of the two
Um34 lacking tRNAs in that the level of the
Um34 Sec tRNA[Ser]Sec isoform and the expression
of stress-related selenoproteins are reduced
(reviewed in reference 17) also provides strong
support that this isoform is indeed responsible for
stress-related selenoprotein synthesis.
How does the Um34 Sec tRNA[Ser]Sec isoform
regulate stress-selenoprotein synthesis? We
examined many of the more likely features that
might be expected to play a role in the selective
expression of selenoproteins by the Um34 isoform
(37). These included nucleotide context of the
UGA Sec codon, the total length of the cDNA
coding region, the number of exons within the
gene, the exon within the gene wherein the UGA
resides, the number of nucleotides between the
UGA Sec codon and the stop codon, the number of
nucleotides between the stop codon and the highly
conserved AUGA sequence within the SECIS
element, and the number of nucleotides between
the highly conserved AUGA sequence within the
SECIS element and the downstream poly A signal.
We concluded that none of these components are
likely involved. Remaining candidates for
mediating the effects of Um34 include the
uncharacterized Um34 methylase and/or different
SECIS-binding proteins. Interestingly, a new
SECIS-binding protein that preferentially binds to
different selenoprotein mRNAs has been detected
(D. Driscoll, personal communication). We are
currently working to identify and characterize the
Um34 methylase.
Consequences of A34 Sec tRNA[Ser]Sec on
selenoprotein synthesis – Although the anticodon
in the A34 tRNA[Ser]Sec was changed to decode Sec
as well as Cys codons, the 75Se-labeling studies
showed that only natural selenoproteins were
labeled with 75Se. The two tRNA[Ser]Sec isoforms,
tRNA[Ser]SecICA and ACA, apparently do not replace
Cys in the general protein population, likely
because tRNA[Ser]Sec associates with a specific
elongation factor (EFsec) rather than EF-1alpha.
However, both mutant tRNAs have the potential to
translate Cys codons, UGU and UGC, with a
preference for UGU (see Fig. 6). The
demonstrated ability of tRNA[Ser]SecICA to translate
UGA (Figs. 3 and 5) indicates that it utilizes the
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(Schweizer et al, submitted for publication) and in
skin function and development (unpublished data).
The above useful models are surpassed by the
one presented here which allows alteration of the
selenoprotein population in liver with wild type or
mutant trsp transgenes. These mice are
phenotypically normal, allowing study of the role
of selenium, housekeeping selenoproteins and
stress-related selenoproteins as well as the entire
selenoprotein population in resistance to various
factors,
such
as
toxic
metabolites,
hepatocarcinogens and liver cancer driver genes.
The approach of targeting specific tissues for trsp
removal can be used to generate other model
systems for studying the role of selenium and
selenoproteins in tissues of interest. The
possibility that the expression of G37 and A34
mutant tRNAs[Ser]Sec in all tissues and organs may
hinder experimentation seems not to be an issue.
The high copy G37 transgenic mouse, which
expresses G37 tRNA in all tissues and organs, has
been used to show that selenoproteins and low
molecular weight selenocompounds have a role in
colon cancer prevention (49) and selenoproteins in
prostate cancer prevention (50). The major
advantage of the current model is that we can
target the removal of trsp and then replace or
partially replace the selenoprotein population. The
targeted mouse models presented in this study are
amongst the most sophisticated mouse models
developed to date for studying the role of
selenium, selenoproteins and low molecular
weight selenocompounds in health and
development.
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FIGURE LEGENDS
Fig. 1. 75Se-Labeling of selenoproteins in A34 transgenic mice. Two of the A34 transgenic mouse lines
encoding four copies of mutant transgenes (heterozygous animals containing a single allele with four
copies) and encoding 12 copies of the mutant transgenes (homozygous animals containing two alleles
with six copies/allele) were labeled with 75Se, protein extracts prepared from liver and kidney and
electrophoresed. Gels were stained with Coomassie blue to assess the total protein population (see lower
panels) and 75Se-labeled proteins detected using a PhosphorImager (see upper panels). Molecular weights
of the protein markers are shown on the left of the panels and selenoprotein identity is indicated on the
right by arrows (see also references 22, 27 and 33 for identification of selenoproteins, and Fig. 3 and its
legend). Details of the 75Se-labeling experiments are given in Experimental Procedures.

Fig. 3. 75Se-Labeling of selenoproteins. A) The six mouse lines were labeled with 75Se. Protein extracts
were prepared from liver, kidney, testes, brain, heart and plasma, and treated as described in the legend to
Figure 1. Molecular weights of the protein markers are shown on the left of the panels and selenoproteins
are indicated on the right by arrows. Selenoprotein identifications are based on references 22, 27 and 33.
The arrows in the Coomassie Blue stained gel in the lower liver panel indicate glutathione S-transferase,
GST, identified in an earlier study (27) and an unidentified protein (indicated with a question mark) that
varied inconsistently in amounts in liver of the mutant trspt transgenic mice (see text). During preparation
of plasma from trsp and Δtrsp mice, greater hemolysis of the red blood cells occurred which accounted
for the globin observed in the Commassie Blue stained gels (see lanes 1 and 6 in the Plasma panel). B)
75
Se-labeled TR1 was purified from crude extracts of liver and kidney using ADP Sepharose 4B prior to
gel electrophoresis as described in Experimental Procedures. Partially purified 75Se-labeled TR1 from the
two organs is shown.
Fig. 4. Northern blot analysis. RNA was extracted from liver and kidney of the six mouse strains and
electrophoresed. RNA was then transblotted onto the appropriate membrane and hybridized with the
indicated probes. Relative labeling was assessed using a PhosphorImager as described in Experimental
Procedures. Staining of developed gels with ethidium bromide showed that identical amounts of 18s and
28s rRNA were present in all tissue extracts (loading control, data not shown). Each of the Northerns
shown was carried out separately on two occasions with tissues from different mice with similar results.
SelK mRNA was not examined in liver and kidney of low copy G37 mice as the levels of SelK mRNA
from both A34 or high copy G37 mice were very similar.
Fig. 5. Western blot analysis. Protein extracts were prepared from liver and kidney from the six mouse
lines and electrophoresed. Protein was then transblotted onto the appropriate membrane and treated with
the appropriate antibodies as described in Experimental Procedures. Selenoproteins are labeled on the left
of each panel.
Fig. 6. Fractionation, sequencing and codon recognition studies. Transfer RNA was isolated from five
mouse lines (A34, high copy G37, and trspt transgenic mice, and trsp and Δtrsp mice), aminoacylated
with 3H-serine and the resulting 3H-seryl-tRNAs chromatographed on a RPC-5 column as described in
Experimental Procedures. The graph shows 3H-seryl-tRNA[Ser]Sec from the A34 mouse line, the arrows
indicate the fractions from which small aliquots of the two peaks were taken for sequencing and ICA and
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Fig. 2. Genotyping of mouse strains. DNA was isolated from liver and kidney of the 6 mouse lines (Table
1) and PCR products (indicated on the left of the figure) were generated with the primers (indicated on the
right) as described in Experimental Procedures. PCR of trspfl (wild type floxed gene) yielded a 1180 bp
fragment, of trsp, (wild type gene) a 980 bp fragment, of Δtrsp (knocked out gene), a 500 bp fragment, of
trspt, A34 or G37 (either wild type, A34 or G37 transgene), a 1072 bp fragment, and of AlbCre (Alb
promoter controlling expression of the Cre recombinase gene), a 370 bp fragment (see also 27).

14
ACA show the anticodon sequences determined from sequencing these samples. The hatched areas show
the fractions pooled for coding studies which were carried out using 10,000 total cpm of Peak I/assay
wherein the cpm bound to ribosomes in the absence of codon were 1,170, and using 10,000 total cpm of
Peak II/assay wherein the cpm bound to ribosomes in the absence of codon were 1,452. CPM bound to
ribosomes in the absence of codon were subtracted from the cpm bound in the presence of codon and
given as ΔCPM Bound. The inset shows the corresponding 3H-seryl-tRNA[Ser]Sec isoforms from the other
four mouse lines and the relative cpm at the highest point of each peak. The fraction numbers of each
highest point shown in brackets were: G37, 14,010 cpm [19]; trsp, 5,065 cpm [49]; and trspt, 37,805 cpm
[44]. The distributions of the two isoforms were determined as described previously (22): ICA and ACA
were present at 66.6% and 33.4% respectively.

Downloaded from www.jbc.org at UNIV OF NEBRASKA - Lincoln on October 10, 2007

15
TABLE 1. Summary of breeding schemes for generating experimental mouse linesa,e

Matingsa
1st breeding

F2
(experimental
mice)e
Designationf
a

A34
transgenicc
(2 copies)

trspt/t
X
trspfl/+-AlbCre+/+

trsp+/+-A34t/t
X
trspfl/+-AlbCre+/+

trsp+/+-G37t/t
X
trspfl/+-AlbCre+/+

trspfl/+-AlbCre+/-trspt/X
trspfl/+-AlbCre+/-trspt/-

trspfl/+-AlbCre+/-A34t/X
trspfl/+-AlbCre+/-A34t/-

trspfl/+-AlbCre+/-G37t/X
trspfl/+-AlbCre+/-G37t/-

trspfl/+-AlbCre+/X
trspfl/+-AlbCre+/-

trsp+/+AlbCre+/+

trspfl/fl-AlbCre+/+trspt/t

trspfl/flAlbCre+/+-A34t/t

trspfl/flAlbCre+/+-G37t/t

trspfl/flAlbCre+/+

trsp

trspt

A34

G37

∆trsp

Wild
typeb,c

trsp+/+
X
trspfl/+AlbCre+/+
trsp+/+AlbCre+/X
trsp+/+AlbCre+/-

Δtrsp
knockoutc
trspfl/fl
X
trsp+/+AlbCre+/+

Matings to obtain each mouse line used in this study are shown in the table.
Both wild type mice, designated trsp in the text, and wild type selenoprotein replacement mice, designated trspt in
the text, were used as control mice.
c
Genotype designations denote the following: trsp+ (wild type Sec tRNA[Ser]Sec gene), trspfl (floxed Sec tRNA[Ser]Sec
gene); trspt (Sec tRNA[Ser]Sec transgene); Δtrsp (liver trsp knockout); AlbCre (albumin Cre gene); A34 (A34 mutant
transgene); and G37 (G37 mutant transgene). Homozygous genotypes and the corresponding heterozygous
genotypes are designated as follows: trsp+/+ and trsp+/- (wild type Sec tRNA[Ser]Sec gene); trspfl/fl and trspfl/+ (floxed
Sec tRNA[Ser]Sec gene); trspt/t and trspt/- (wild type Sec tRNA[Ser]Sec transgene); AlbCre+/+ and AlbCre+/- (albumin Cre
gene); A34t/t and A34t/- (A34 transgene); and G37t/t and G37t/- (G37 transgene).
d
G37 transgenic mice carrying 2 or 16 copies of the transgene are referred to in the text as G37 low copy number or
G37 high copy number, respectively.
e
Experimental mice are those animals generated from the matings for use in the study.
f
The genotypes shown in the F2 experimental mice are designated in the text as: trsp or wild type control mouse;
trspt or wild type replacement mouse which is also a control mouse; A34 transgenic mouse; G37 transgenic mouse;
Δtrsp or liver knockout mouse.
b
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F1
(2nd breeding)

Wild type
replacement b,c
(20 copies)

G37
transgenicc
(2 or 16
copies)d

16
TABLE 2. Selenium levels in tissues of liver replacement mice
Selenium levels (ppm)a
trsp

trspt

A34

G37 low

G37 high

Δtrsp

Liver

1.40

1.66

0.37

0.43

0.43

0.41

Kidney

1.27

1.50

0.86

1.02

0.63

0.95

Testes

0.81

0.85

0.80

0.78

0.69

0.69

Brain

0.19

0.17

0.16

0.15

0.09

0.16

Plasma

0.40

0.34

0.10

0.17

0.10

0.09

a

Selenium levels were measured as described in Experimental Procedures. Each assay was
carried out in duplicate and values represent the average of at least two different mice of each
genotype.
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Tissue
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TABLE 3. Glutathione peroxidase and TR1 activities
Enzyme activitiesa
Enzyme

Tissue

trsp

trspt

A34

G37 low

G37 high

Δtrsp

I

GPx

Liver

468.4 +48.1

438.4 +54.4

3.8 +1.2

65.3 +11.7

29.2 +2.0

29.0 +10.2

GPx

Kidney

364.7 +27.2

373.6 +12.5

118.2 +38.9

194.6 +33.8

61.5 +10.3

163.4 +18.7

GPx

Testes

20.3 +1.2

21.8 +0.5

14.3 +2.0

10.4 +0.7

7.6 +0.5

20.9 +1.4

GPx

Brain

15.5 +2.0

18.7 +0.2

11.5 +3.1

16.2 +0.8

6.6 +0.4

14.8 +0.9

GPx

Plasma

1369.0 +133.3

1594.0 +135.8

521.1 +7.6

731.6 +173.3

405.0 +55.8

490.4 +105.0

TR1

Liver

1.05 + 0.12

1.02 +0.05

0.74 +0.07

0.90 +0.11

0.46 +0.08

0.25 +0.08

TR1

Kidney

1.11 + 0.07

1.19 + 0.18

1.10 + 0.03

1.01 + 0.07

0.57 + 0.08

1.25 + 0.06

II

a

Glutathione peroxidase (Experiment I) and TR1 activities (Experiment II) were measured in
mice as given in Experimental Procedures. Each assay was carried out in triplicate. Values
expressed are nmol NADPH/min/mg protein or nmol NADPH/min/ml plasma for glutathione
peroxidase activity and ∆A412/mg protein for TR1 activity.
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